Affordable HIV Medication Access in Jeopardy Across the US
Thousands lose HIV treatment coverage as states move to limit access to affordable medications, sparking concerns over public health and patient wellbeing.
Access to affordable, life-saving HIV treatments is increasingly under threat across the United States as several states move to restrict coverage and make medications more difficult to obtain. This week, thousands of Floridians were abruptly cut off from benefits that previously helped make critical HIV medications more accessible and affordable. Additionally, the medication Biktarvy, a highly effective HIV treatment, was also dropped from Florida's state Medicaid formulary, further limiting options for patients in the state.
The changes in Florida are part of a troubling nationwide trend, as other states grapple with budgetary constraints and seek to rein in healthcare costs. These policy decisions have significant public health implications, potentially rolling back hard-won progress in HIV treatment and prevention, and threatening the wellbeing of some of the most vulnerable populations.
{{IMAGE_PLACEHOLDER}}Source: The New York Times
